Efficacy and safety of the APE (actinomycin D, cisplatin, etoposide) regimen for the management of high-risk gestational trophoblastic neoplasia.

被引：0
|
作者：
Lhomme, Catherine
Even, Caroline
Duvillard, Pierre
Pautier, Patricia
Floquet, Anne
Kerbrat, Pierre
Troalen, Frederic
Rey, Annie
Balleyguier, Corinne
Morice, Philippe
Fizazi, Karim
Droz, Jean Pierre
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Inst Gustave Roussy, Dept Pathol, Villejuif, France
[3] Inst Bergonie, Bordeaux, France
[4] Ctr Eugene Marquis, Rennes, France
[5] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[6] Ctr Leon Berard, F-69373 Lyon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5028
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia
    Even, C.
    Pautier, P.
    Duvillard, P.
    Floquet, A.
    Kerbrat, P.
    Troalen, F.
    Rey, A.
    Balleyguier, C.
    Tazi, Y.
    Leary, A.
    Augereau, P.
    Morice, P.
    Droz, J. -P.
    Fizazi, K.
    Lhomme, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (12) : 2082 - 2089
  • [2] Management of High-Risk Gestational Trophoblastic Neoplasia with Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide, Vincristine Chemotherapy
    Cyriac, Sanju
    Rajendranath, Rejiv
    Sridevi, Veluswami
    Sagar, Tenali G.
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2011, 56 (5-6) : 219 - 223
  • [3] Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia
    Cyriac, Sanju
    Rajendranath, Rejiv
    Sridevi, Veluswami
    Sagar, Tenali G.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2011, 115 (01) : 37 - 39
  • [4] Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy
    Escobar, PF
    Lurain, JR
    Singh, DK
    Bozorgi, K
    Fishman, DA
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 91 (03) : 552 - 557
  • [5] Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen
    Mao, Yuyan
    Wan, Xiaoyun
    Lv, Weiguo
    Xie, Xing
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2007, 98 (01) : 44 - 47
  • [6] The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia
    Sato, Shizuka
    Yamamoto, Eiko
    Niimi, Kaoru
    Ino, Kazuhiko
    Nishino, Kimihiro
    Suzuki, Shiro
    Kotani, Tomomi
    Kajiyama, Hiroaki
    Kikkawa, Fumitaka
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (01) : 203 - 209
  • [7] The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia
    Shizuka Sato
    Eiko Yamamoto
    Kaoru Niimi
    Kazuhiko Ino
    Kimihiro Nishino
    Shiro Suzuki
    Tomomi Kotani
    Hiroaki Kajiyama
    Fumitaka Kikkawa
    [J]. International Journal of Clinical Oncology, 2020, 25 : 203 - 209
  • [8] Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors
    Matsui, H
    Suzuka, K
    Iitsuka, Y
    Seki, K
    Sekiya, S
    [J]. GYNECOLOGIC ONCOLOGY, 2000, 78 (01) : 28 - 31
  • [9] High-Risk Metastatic Gestational Trophoblastic Neoplasia Primary Management with EMA-CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Chemotherapy
    Cagayan, Ma. Stephanie Fay S.
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (5-6) : 231 - 236
  • [10] Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia
    Baptista, Angela M.
    Belfort, Paulo
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 119 (01) : 35 - 38
12345